Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
Clinical trial NCT01018056 · COMPLETED
Trial details
- NCT number
- NCT01018056
- Sponsor
- Johns Hopkins University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.